首页 正文

Early health technology assessments in pharmacogenomics: a case example in cardiovascular drugs

{{output}}
Aim: To assess the required characteristics (cost, sensitivity and specificity) of a pharmacogenomic test for being a cost-effective prevention of angiotensin-converting enzyme inhibitors induced angioedema. Furthermore, we asses... ...